You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API ARIPIPRAZOLE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ARIPIPRAZOLE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Carwin Pharmaceutical Associates LLC OPIPZA aripiprazole 15370-401 FD&C BLUE NO. 1
Carwin Pharmaceutical Associates LLC OPIPZA aripiprazole 15370-401 GLYCERIN
Carwin Pharmaceutical Associates LLC OPIPZA aripiprazole 15370-401 HYDROXYPROPYL CELLULOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for ARIPIPRAZOLE

Excipient focus: ACESULFAME POTASSIUM

Excipient focus: ALUMINUM

Excipient focus: ALUMINUM OXIDE

Excipient focus: ASPARTAME

Excipient focus: BENZYL ALCOHOL

Excipient focus: BUTYLATED HYDROXYANISOLE

Excipient focus: CALCIUM STEARATE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77492

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: CUPROUS CHLORIDE

Excipient focus: EDETATE DISODIUM

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FRUCTOSE

Excipient focus: GLYCERIN

Excipient focus: GOLD

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALIC ACID

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN

Excipient focus: ORANGE

Excipient focus: PEPPERMINT

Excipient focus: PHOSPHORIC ACID

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYSORBATE 20

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SILICA

Excipient focus: SILICON

Excipient focus: SILICON DIOXIDE

Excipient focus: SILICON NITRIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

Excipient focus: SORBITAN MONOLAURATE

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: TARTARIC ACID

Excipient focus: TITANIUM

Excipient focus: TRIETHYL CITRATE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: VANILLA

Excipient focus: WATER

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links